Literature DB >> 35432991

Osteoclast-like giant cell tumor of the parotid gland; a case report with literature review.

Abdulwahid M Salih1,2, Berwn A Abdulla2,3, Ari M Abdullah2,4, Fahmi H Kakamad1,2,3, Zana H Hassan5, Razhan K Ali6, Suhaib H Kakamad3.   

Abstract

Introduction: The osteoclast-like giant cell is a benign tumor that presents as either an isolated benign tumor or one with a carcinomatous component. This study aims to report a rare case of osteoclast-like giant cell tumor (GCT) of the parotid gland. Case report: A 67-year-old female presented with a painless left pre-auricular swelling of 2-month duration which increased in size gradually over that period. On examination, there was a firm, mobile mass with well-defined borders in the left parotid gland. Fine needle aspiration cytology showed a giant cell-rich lesion that was highly cellular and contained a large number of osteoclast-like multinucleated giant cells, with clusters of spindle and epithelioid cells. Total parotidectomy was performed. After the operation, the patient was sent for radiotherapy. Discussion: The histogenesis and exact nature of this tumor are unknown although numerous ideas have been put forward. The most common clinical manifestation is a painless slow-growing tumor in the parotid area. Primary osteoclast-like GCT of the salivary gland might show concomitant benign or malignant neoplasms. There is also a "pure form" of the tumor that has no accompanying neoplasm.
Conclusion: GCT of the parotid gland is a rare tumor. The histogenesis and nature of parotid gland GCT are not completely understood. The treatment of choice is total excision followed by radiotherapy.
© 2022 The Authors.

Entities:  

Keywords:  Giant cell tumor; Osteoclast-like giant cell tumor; Parotid gland; Salivary gland

Year:  2022        PMID: 35432991      PMCID: PMC9006646          DOI: 10.1016/j.amsu.2022.103509

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


Introduction

Giant cell tumor (GCT) of bone is a benign osteolytic bone tumor that is filled with osteoclast-like multinucleated giant cells (MGCs) and contributes to about 5% of all primary bone tumors in adults. It leads to extensive bone destruction [1,2]. The abnormal process of osteoclastogenesis in the GCT of bone has an unexplained underlying mechanism. The origin of a GCT is typically thought to be the bone, but it has also been found in the pancreas, thyroid, lung, liver, breast, ovary, and kidney. It has also been observed among other soft tissue and parenchymal organs, such as the parotid and salivary glands [3,4]. Osteoclast-like GCT of the parotid is a benign soft tissue tumor that has the potential to become malignant. It is uncommon and only a few cases have been recorded in literature [4]. They have been thought to be either a part of a stromal process reacting to neoplasia or a component of a primary neoplasm; however, their exact etiology is unclear [5]. There have been two types of presentations: either an isolated GCT or a tumor with a carcinomatous component [6,7]. This study aims to present a rare case of extraosseous GCT of the major salivary gland. The report has been written in line with SCARE 2020 guidelines [8].

Case report

Patient Information: A 67-year-old female presented with a painless left pre-auricular swelling of 2-month duration which increased in size over that period. The patient was diabetic and hypertensive, and hence, was taking anti-diabetic and anti-hypertensive medications. Her past medical history aside from that was not significant. Clinical Findings: On examination, there was a painless, firm, and mobile mass with well-defined borders in the left parotid gland. No skin changes or ulceration over the mass were observed. Diagnostic Assessment: Hematological examinations revealed HbA1c of 7.7%, a blood sugar level of 227mg/dl, and an inflammatory marker (CRP) of 3.18 mg/l. On ultrasound examination, there was a well-defined hypoechoic solid nodule of about 33 × 27*11 mm in the left preauricular region. The nodule was in contact with the ramus of the mandible and showed malignant characteristics - along with a 7mm short axis lymph node seen in the left infra-auricular region without pathological sonographic characteristics. No obvious pathological lymph node was seen elsewhere in the neck. Fine needle aspiration cytology (FNAC) was performed which showed a giant cell-rich lesion that was highly cellular and contained a large number of osteoclast-like multinucleated giant cells with clusters of spindle and epithelioid cells (stroma) and a few lobulated benign-looking acini of parotid glands. The patient was sent for contrast magnetic resonance (MRI) imaging of the neck which revealed a single well-defined lesion in the superficial lobe in the left parotid gland measuring about 33 × 20 mm and showing a heterogeneous signal on T1 and T2, suggesting mostly pleomorphic adenoma. The right parotid gland was normal with bilateral benign-looking cervical lymph nodes of 6mm in the short axis - with normal submandibular and thyroid glands. The pharynx and larynx were normal. Therapeutic Intervention: Superficial-deep parotidectomy was performed on the patient. The result of histopathological examination revealed a giant cell tumor of 3.4 cm without any lymph node involvement (Fig. 1). The tumor resection margin was 1.5 cm. After the operation, the patient was sent for radiotherapy.
Fig. 1

Microscopic photo of the specimen revealing a well demarcated mass composing of evenly distributed osteoclast-like multinucleated giant cells (black arrows) intermixed with other population of mono-nuclear spindle cells (red arrow) having abundant eosinophilic cytoplasm, low mitotic count (1–3 mitoses/10 HPF) with brown pigment deposition (red star). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Microscopic photo of the specimen revealing a well demarcated mass composing of evenly distributed osteoclast-like multinucleated giant cells (black arrows) intermixed with other population of mono-nuclear spindle cells (red arrow) having abundant eosinophilic cytoplasm, low mitotic count (1–3 mitoses/10 HPF) with brown pigment deposition (red star). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Follow up: the patient was well and healthy six months after the operation.

Discussion

A GCT is a lesion that develops from undifferentiated mesenchymal cells in the bone marrow and has a marginal or ambiguous biological activity. This, however, is not recognized as a salivary gland tumor by the World Health Organization (WHO). The histogenesis of this tumor is unknown although numerous hypotheses have been put forward [9]. We could collect only 16 cases from the literature, indicating that GCT of the parotid gland is very uncommon. Eusebi was the first to describe the GCT of the parotid gland [6]. The most common clinical manifestation is a painless slow-growing tumor in the parotid area [10]. The patients in the cases gathered by Deligiannidis et al. ranged in age from 24 to 92 years old, and the tumors were found to be more common in men than in women; the mean age of occurrence was 56 years [11]. In previous incidents, a link between primary osteoclast-like GCT of the salivary gland and concomitant benign and malignant neoplasms was reported [9,12]. There is also a “pure form” of the tumor that has no accompanying malignancy [13]. Because malignancy was identified in the majority of the patients, the frequency with which parotid gland GCT coexists with malignant neoplasms is of particular interest [9]. The parotid gland, mandible, or soft tissues around the parotid gland can all cause GCT in the parotid area. The so-called GCT of the parotid gland appears to share some features with other GCTs, hinting that they have a separate etiology. The first feature is the tumor's link to neighboring anatomical components, as shown intraoperatively because extra-parotid tumors appear to be a continuation of their tissues of origin, whereas parotid tumors are distinct from the parotid [14]. Furthermore, unlike GCT of the bone, there is no reactive bone production in the periphery of parotid gland tumors [14]. Finally, they exhibit more aggressive biological behavior, which has been linked to a higher prevalence of concomitant malignancy [9]. Based on the expression of epithelial and histiocytic markers from mononuclear cells, as well as their higher coincidence with malignant findings, some investigators claim that GCT of the parotid gland has an epithelial origin and looks more like carcinomas [9]. Despite efforts to shed light on the matter, the specific cause of this tumor remains unknown. The recommended treatment, despite the vague nature of the tumor, is total excision of the lesion with healthy tissue margins to reduce the likelihood of recurrence, particularly those with associated malignancy. For patients with poor resection margins or those who cannot undergo surgery owing to underlying problems, radiotherapy can be considered to play a role in the treatment of these lesions [10]. In conclusion, GCT of the parotid gland is a rare tumor. The histogenesis and nature of parotid gland GCT are not completely understood. It differs from GCT of bone in that it is not a continuation of neighboring tissues and there is no reactive bone production. The treatment of choice is total excision followed by radiotherapy.

Sources of funding

None is found.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Research registration

Not applicable.

Ethical Approval

N/A.

Author statement

Abdulwahid M. Salh: Surgeon performing the operation, final approval of the manuscript. Zana H. Hassan: literature review, writing the manuscript, final approval of the manuscript. Razhan K. Ali, Suhaib H. Kakamad, Berwn A. Abdulla, Fahmi H. Kakamad: literature review, review and final approval of the manuscript. Ari M. Abdullah: The histopathologist who made the diagnosis, final approval of the manuscript.

Guarantor

Fahmi Hussein Kakamad is Guarantor of this submission.

Registration of Research Studies

N/A.

Declaration of competing interest

None to be declared.
  12 in total

1.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

2.  A case of giant cell tumor of the parotid gland.

Authors:  Y Itoh; Y Taniguti; K Arai
Journal:  Ann Plast Surg       Date:  1992-02       Impact factor: 1.539

3.  Giant cell tumor of major salivary glands: report of three cases, one occurring in association with a malignant mixed tumor.

Authors:  V Eusebi; S A Martin; E Govoni; J Rosai
Journal:  Am J Clin Pathol       Date:  1984-05       Impact factor: 2.493

4.  [Osteoclast-type giant cell tumor of the parotid gland].

Authors:  S Rammeh; I Hergli; M K M'farrej; N Znaidi; S Nechi; R Zermani
Journal:  Rev Stomatol Chir Maxillofac Chir Orale       Date:  2014-03-20

5.  Low to intermediate grade salivary duct carcinoma associated with osteoclast like-giant cell tumor of parotid gland: a rare case with distinct pathological features.

Authors:  Sunil Pasricha; Jatin S Gandhi; Anurag Mehta; Gurudutt Gupta; Tapaswini Pradhan
Journal:  J Cancer Res Ther       Date:  2013 Apr-Jun       Impact factor: 1.805

6.  Diagnosing mycobacterial lymphadenitis in children using fine needle aspiration biopsy: cytomorphology, ZN staining and autofluorescence -- making more of less.

Authors:  Colleen A Wright; Mirjam van der Burg; D Geiger; Jeroen G Noordzij; Steven M Burgess; Ben J Marais
Journal:  Diagn Cytopathol       Date:  2008-04       Impact factor: 1.582

Review 7.  Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"?

Authors:  Loretta L Y Tse; Sydney D Finkelstein; Richard W Siegler; Leon Barnes
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

8.  Osteoclastomalike giant cell tumor of the parotid gland: report of a case with fine needle aspiration diagnosis.

Authors:  Simin Torabinezad; Perikala V Kumar; Seyed Baseer Hashemi; Abbass Rahimi
Journal:  Acta Cytol       Date:  2006 Jan-Feb       Impact factor: 2.319

Review 9.  Giant cell tumor of bone.

Authors:  William M Mendenhall; Robert A Zlotecki; Mark T Scarborough; C Parker Gibbs; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2006-02       Impact factor: 2.339

10.  Features of a giant cell tumour of the parotid gland: A case report.

Authors:  Cheng-Jung Wu; Pi-Hsiung Wu; Sau-Tung Chu; Wei-Wen Yu; Po-Chun Chen
Journal:  Oncol Lett       Date:  2013-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.